Revive Therapeutics Ltd (RVVTF)

[ReikoBlack]

For what it's worth, i emailed Michael Frank yesterday & today with a few simple questions. I haven't received a response back. Maybe he can't answer my questions or he doesn't like me. :(

Sent Mon, Jan 25 at 3:44 PM & Tue, Jan 26 at 9:58 AM
"Mr. Michael Frank,

In a Press Release on October 25, 2020 the Company stated that, “it is estimated that over 200 patients will have completed the Study for the interim analysis by the end of December 2020”.

In a Press Release on December 23, 2020 the Company stated that, “the Company is on pace to meet its enrollment goals for the Independent Data and Safety Monitoring Board (“DSMB”) to review the safety and efficacy data from the 210 patients as part of the first interim analysis of patients treated and followed up for 28 days after randomization”.

We’re now in the latter part of January 2021. Has the 210 patients threshold been met? If so, is the DSMB now in the process of reviewing the data and will the Company publicly release the results?

Thank you,
xxxxx xxxxxxxxx
Revive Therapeutics Shareholder"

Who thinks we'll hear Data results on the scheduled date, February 1? That's NEXT MONDAY -